display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HER2-positivemetastatic/advanced - breast cancer (mBC)
la/mBC - HER2 positive - 2nd Line (L2)metastatic/advanced - breast cancer (mBC)
trastuzumab deruxtecan DESTINY Breast03 DESTINY-Breast04

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons